EL
46
-2
BAC
69
-2
IFF
54
-2
ACN
54
2
NKE
34
-2
MNST
46
-11
MAT
47
-3
VRSN
42
-3
IR
65
2
NSC
57
-3
CL
56
2
DE
40
-2
BA
38
-2
LYB
13
2
MAC
62
2
PNC
75
3
HPE
66
5
FIS
63
-4
WAT
49
-3
NOC
45
-2
EL
46
-2
BAC
69
-2
IFF
54
-2
ACN
54
2
NKE
34
-2
MNST
46
-11
MAT
47
-3
VRSN
42
-3
IR
65
2
NSC
57
-3
CL
56
2
DE
40
-2
BA
38
-2
LYB
13
2
MAC
62
2
PNC
75
3
HPE
66
5
FIS
63
-4
WAT
49
-3
NOC
45
-2
Financhill
Back

State Street Financial Sel Sec SPDR ETF Vs. Kymera Therapeutics, Inc. Industry Stock Comparison

Buy
76

XLF
State Street Financial Sel Sec SPDR ETF

Last Price:
$53.87
Seasonality Move:
0.78%
Buy
87

KYMR
Kymera Therapeutics, Inc.

Last Price:
$89.98
Seasonality Move:
7.7%
Buy
76
State Street Financial Sel Sec SPDR ETF (XLF) is a Buy

Is State Street Financial Sel Sec SPDR ETF a Buy, Sell or Hold?

  • The current State Street Financial Sel Sec SPDR ETF [XLF] share price is $53.28. The Score for XLF is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
  • XLF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
87
Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Kymera Therapeutics, Inc. [KYMR] share price is $86.88. The Score for KYMR is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

XLF Stock Price Chart

What is State Street Financial Sel Sec SPDR ETF's stock price today?

  • The State Street Financial Sel Sec SPDR ETF share price today is $53.28
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XLF is experiencing selling pressure, which indicates risk of future bearish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

  • The Kymera Therapeutics, Inc. share price today is $86.88
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

XLF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.69 Buy
Relative Strength Index (14 RSI): 55.03 Buy
Chaikin Money Flow: -42363790 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.91 - 53.43) Buy
Bollinger Bands (100): (52.18 - 53.68) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.97 Buy
Relative Strength Index (14 RSI): 72.81 Buy
Chaikin Money Flow: -897315 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.72 - 73.96) Buy
Bollinger Bands (100): (43.27 - 64.19) Buy

XLF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.34 Sell
20-day SMA: 52.68 Buy
50-day SMA: 52.79 Buy
200-day SMA: 51.43 Buy
8-day EMA: 52.9 Buy
20-day EMA: 45.78 Buy
50-day EMA: 29.06 Buy
200-day EMA: 9.55 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.38 Buy
20-day SMA: 67.89 Buy
50-day SMA: 62.54 Buy
200-day SMA: 44.51 Buy
8-day EMA: 75.59 Buy
20-day EMA: 69.41 Buy
50-day EMA: 62.91 Buy
200-day EMA: 49.79 Buy

State Street Financial Sel Sec SPDR ETF Earnings Growth & XLF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.36 per share.

State Street Financial Sel Sec SPDR ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):